Literature DB >> 9521472

Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?

T W Jacobs1, K P Siziopikou, J E Prioleau, S Raza, J K Baum, D F Hayes, S J Schnitt.   

Abstract

Core needle biopsies (CNB) are often used for the diagnosis of breast lesions. In some breast cancer patients, e.g., those treated with preoperative chemotherapy, the CNB specimen might be the only pretreatment tissue sample available for studies of prognostic and predictive markers. Our purpose was to evaluate whether marker studies performed on CNB specimens accurately reflect the marker status of the tumor. Immunostaining for five commonly used prognostic and predictive markers was performed on both CNB and subsequent excision specimens from 56 consecutive patients who had a CNB with carcinoma followed by excision of the tumor. None of the patients received radiotherapy or chemotherapy between the CNB and the excision. Paraffin sections of the CNB and excision specimens were immunostained for bcl-2, estrogen receptor (ER), c-erbB-2, and p53. These markers were scored as positive or negative. Microvessel density (MVD) was scored as a continuous variable on sections immunostained for Factor VIII-related antigen by calculating the average number of microvessels in three 224x fields of highest tumor vascularity ("hot spots"). Immunostaining results for bcl-2, ER, c-erbB-2, and p53 on the CNB and the corresponding excision specimens were 100% concordant. Although there was significant correlation between MVD on the CNB specimens and the corresponding excisions (r = 0.507, P = 0.0002), the mean MVD on the CNB and corresponding excision specimens differed by more than 10% in 85.7% of cases, with differences ranging from 4.3 to 233.3%. MVD was higher in the CNB than in the excision specimens in 30 (61.2%) of 49 cases. In conclusion, in all of the cases studied, accurate results for the dichotomously scored markers bcl-2, ER, c-erbB-2, and p53 were obtained on CNB specimens. In contrast, in most cases, MVD, which was scored as a continuous variable, could not be reliably assessed on the CNB specimen.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521472

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  15 in total

1.  Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer.

Authors:  Julie M Wu; Marc K Halushka; Pedram Argani
Journal:  Hum Pathol       Date:  2010-03-24       Impact factor: 3.466

Review 2.  An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens.

Authors:  E A Rakha; I O Ellis
Journal:  J Clin Pathol       Date:  2007-07-14       Impact factor: 3.411

Review 3.  The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Authors:  Zsolt Hodi; Jayeta Chakrabarti; Andrew H S Lee; John E Ronan; Christopher W Elston; Kwok Leung Cheung; John F R Robertson; Ian O Ellis
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

4.  Evaluation of Ki-67 and Bcl-2 antigen expression in breast carcinomas of women treated with raloxifene.

Authors:  P V Lopes-Costa; A R dos Santos; L G dos Santos; B B da Silva
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

5.  Her-2/neu gene amplification compared with HER-2/neu protein overexpression on ultrasound guided core-needle biopsy specimens of breast carcinoma.

Authors:  H Kaya; T Ragazzini; E Aribal; I Güney; E Kotiloglu
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

Review 6.  [Beyond staging, typing and grading. New challenges in breast cancer pathology].

Authors:  H H Kreipe; P Ahrens; M Christgen; U Lehmann; F Länger
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

7.  Effect of raloxifene on vascular endothelial growth factor expression in breast carcinomas of postmenopausal women.

Authors:  B B da Silva; A R dos Santos; C G Pires; P V Lopes-Costa
Journal:  Cell Prolif       Date:  2009-05-29       Impact factor: 6.831

8.  In vivo microcartography and subcellular imaging of tumor angiogenesis: a novel platform for translational angiogenesis research.

Authors:  Mark P S Dunphy; David Entenberg; Ricardo Toledo-Crow; Steven M Larson
Journal:  Microvasc Res       Date:  2009-04-09       Impact factor: 3.514

9.  Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.

Authors:  Sibel Yenidunya; Reyhan Bayrak; Hacer Haltas
Journal:  Diagn Pathol       Date:  2011-03-13       Impact factor: 2.644

10.  Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.

Authors:  Susanne Taucher; Margaretha Rudas; Robert M Mader; Michael Gnant; Peter Dubsky; Sebastian Roka; Thomas Bachleitner; Daniela Kandioler; Günther Steger; Martina Mittlböck; Raimund Jakesz
Journal:  Wien Klin Wochenschr       Date:  2004-01-31       Impact factor: 2.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.